Compare OPK & ERII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPK | ERII |
|---|---|---|
| Founded | 2006 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 400.7M |
| IPO Year | 2011 | 2008 |
| Metric | OPK | ERII |
|---|---|---|
| Price | $1.57 | $7.06 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $1.60 | ★ $17.07 |
| AVG Volume (30 Days) | ★ 2.7M | 880.6K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 5.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $606,879,000.00 | $134,987,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.24 | $20.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.98 | $7.25 |
| 52 Week High | $1.73 | $18.31 |
| Indicator | OPK | ERII |
|---|---|---|
| Relative Strength Index (RSI) | 56.43 | 33.65 |
| Support Level | $1.12 | N/A |
| Resistance Level | $1.58 | $8.05 |
| Average True Range (ATR) | 0.07 | 0.23 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 38.18 | 14.29 |
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Energy Recovery Inc designs and manufactures energy-saving technologies. The firm uses its proprietary pressure exchanger technology to help customers in multiple industries improve their operations and lower their emissions. Using its proprietary technology, it offers energy recovery devices, including pressure exchangers, pumps, and turbochargers, mainly used for seawater desalination and wastewater treatment. Additionally, the company is involved in the development of emerging technologies, such as the PX G1300 used in industrial and commercial refrigeration applications. The firm's reportable operating segments are: Water, which generates maximum revenue, and Emerging Technologies. Geographically, it generates maximum revenue from the Middle East, and the rest from other markets.